Available studies (145 found)
| Short citation | Full citation | Bioassay | Epidemiology | Epi. meta-analysis | In vitro | Ecology |
|---|---|---|---|---|---|---|
| Dong 2012a | Dong GH, Zhang YH, Zheng L, Liang ZF, Jin YH, and He QC. 2012. Subchronic effects of perfluorooctanesulfonate exposure on inflammation in adult male C57BL/6 mice. Environ Toxicol 27(5): 285-296. PubMed DOI | |||||
| Dong 2012b | Dong GH, Wang J, Zhang YH, Liu MM, Wang D, Zheng L, and Jin YH. 2012. Induction of p53-mediated apoptosis in splenocytes and thymocytes of C57BL/6 mice exposed to perfluorooctane sulfonate (PFOS). Toxicol Appl Pharmacol 264(2): 292-299. PubMed DOI | |||||
| Dong 2013 | Dong GH, Tung KY, Tsai CH, Liu MM, Wang D, Liu W, Jin YH, Hsieh WS, Lee YL, and Chen PC. 2013. Serum polyfluoroalkyl concentrations, asthma outcomes, and immunological markers in a case-control study of Taiwanese children. Environ Health Perspect 121(4): 507-513, 513e501-508. PubMed DOI | |||||
| Emmett 2006 | Emmett EA, Zhang H, Shofer FS, Freeman D, Rodway NV, Desai C, and Shaw LM. 2006. Community exposure to perfluorooctanoate: Relationships between serum levels and certain health parameters. J Occup Environ Med 48(8): 771-779. PubMed | |||||
| Fair 2011 | Fair PA, Driscoll E, Mollenhauer MA, Bradshaw SG, Yun SH, Kannan K, Bossart GD, Keil DE, and Peden-Adams MM. 2011. Effects of environmentally-relevant levels of perfluorooctane sulfonate on clinical parameters and immunological functions in B6C3F1 mice. J Immunotoxicol 8(1): 17-29. PubMed DOI | |||||
| Fair 2013 | Fair PA, Romano T, Schaefer AM, Reif JS, Bossart GD, Houde M, Muir D, Adams J, Rice C, Hulsey TC, and Peden-Adams M. 2013. Associations between perfluoroalkyl compounds and immune and clinical chemistry parameters in highly exposed bottlenose dolphins (Tursiops truncatus). Environ Toxicol Chem 32(4): 736-746. PubMed DOI | |||||
| Fairley 2007 | Fairley KJ, Purdy R, Kearns S, Anderson SE, and Meade B. 2007. Exposure to the immunosuppressant, perfluorooctanoic acid, enhances the murine IgE and airway hyperreactivity response to ovalbumin. Toxicol Sci 97(2): 375-383. PubMed | |||||
| Fang 2013 | Fang C, Huang Q, Ye T, Chen Y, Liu L, Kang M, Lin Y, Shen H, and Dong S. 2013. Embryonic exposure to PFOS induces immunosuppression in the fish larvae of marine medaka. Ecotoxicol Environ Saf 92: 104-111. PubMed DOI | |||||
| Fei 2010 | Fei C, McLaughlin JK, Lipworth L, and Olsen J. 2010. Prenatal exposure to PFOA and PFOS and risk of hospitalization for infectious diseases in early childhood. Environ Res 110(8): 773-777. PubMed DOI | |||||
| Genser 2015 | Genser B et al. Within- and between-group regression for improving the robustness of causal claims in cross-sectional analysis. Environ Health 2015; 14 ():60. PubMed DOI | |||||
| Gimenez-Bastida 2015 | Gimenez-Bastida JA, Surma M, Zielinski H. 2015. In vitro evaluation of the cytotoxicity and modulation of mechanisms associated with inflammation induced by perfluorooctanesulfonate and perfluorooctanoic acid in human colon myofibroblasts CCD-18Co. Toxicology In Vitro 29(7): 1683-1691 PubMed DOI | |||||
| Grandjean 2012 | Grandjean P, Andersen EW, Budtz-Jorgensen E, Nielsen F, Molbak K, Weihe P, and Heilmann C. 2012. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. J Am Med Assoc 307(4): 391-397. PubMed DOI | |||||
| Granum 2013 | Granum B, Haug LS, Namork E, Stolevik SB, Thomsen C, Aaberge IS, van Loveren H, Lovik M, and Nygaard UC. 2013. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood. J Immunotox. PubMed DOI | |||||
| Griffith and Long 1980 | Griffith FD, and Long JE. 1980. Animal toxicity studies with ammonium perfluorooctanoate. Am Ind Hyg Assoc J 41(8): 576-583. PubMed | |||||
| Guruge 2009 | Guruge KS, Hikono H, Shimada N, Murakami K, Hasegawa J, Yeung LW, Yamanaka N, and Yamashita N. 2009. Effect of perfluorooctane sulfonate (PFOS) on influenza A virus-induced mortality in female B6C3F1 mice. J Toxicol Sci 34(6): 687-691. PubMed | |||||
| Han 2012 | Han Z, Liu Y, Wu D, Zhu Z, and Lü C. 2012. Immunotoxicity and hepatotoxicity of PFOS and PFOA in tilapia (Oreochromis niloticus). Chinese Journal of Geochemistry 31(4): 424-430. | |||||
| Han 2012 (iv) | Han Z, Liu Y, Wu D, Zhu Z, and Lü C. 2012. Immunotoxicity and hepatotoxicity of PFOS and PFOA in tilapia (Oreochromis niloticus). Chinese Journal of Geochemistry 31(4): 424-430. | |||||
| Hines 2009 | Hines EP, White SS, Stanko JP, Gibbs-Flournoy EA, Lau C, and Fenton SE. 2009. Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: Low doses induce elevated serum leptin and insulin, and overweight in mid-life. Mol Cell Endocrinol 304(1-2): 97-105. PubMed DOI | |||||
| Houde, 2014 | Houde M, Giraudo M, Douville M, Bougas B, Couture P, De Silva AO, Spencer C, Lair S, Verreault J, Bernatchez L, and Gagnon C. 2014. A multi-level biological approach to evaluate impacts of a major municipal effluent in wild St. Lawrence River yellow perch (Perca flavescens). Sci Total Environ 497-498: 307-318. PubMed DOI | |||||
| Hu 2010 | Hu Q, Strynar MJ, and DeWitt JC. 2010. Are developmentally exposed C57BL/6 mice insensitive to suppression of TDAR by PFOA? J Immunotoxicol 7(4): 344-349. PubMed DOI | |||||
| Hu 2012 | Hu Q, Franklin JN, Bryan I, Morris E, Wood A, and DeWitt JC. 2012. Does developmental exposure to perflurooctanoic acid (PFOA) induce immunopathologies commonly observed in neurodevelopmental disorders? Neurotox 33(6): 1491-1498. PubMed DOI | |||||
| Huang 2015 | Huang Q et al. Immunotoxic effects of perfluorooctane sulfonate and di(2-ethylhexyl) phthalate on the marine fish Oryzias melastigma. Fish Shellfish Immunol. 2015; 44 (1):302-6. PubMed DOI | |||||
| Humblet 2014 | Humblet O, Diaz-Ramirez LG, Balmes JR, Pinney SM, and Hiatt RA. 2014. Perfluoroalkyl Chemicals and Asthma among Children 12-19 Years of Age: NHANES (1999-2008). Environ Health Perspect 122(10): 1129-1133. PubMed DOI | |||||
| Innes 2011 | Innes KE, Ducatman AM, Luster MI, and Shankar A. 2011. Association of osteoarthritis with serum levels of the environmental contaminants perfluorooctanoate and perfluorooctane sulfonate in a large Appalachian population. Am J Epidemiol 174(4): 440-450. PubMed DOI | |||||
| Iwai and Yamashita 2006 | Iwai H, and Yamashita K. 2006. A fourteen-day repeated dose oral toxicity study of APFO in rats. Drug Chem Toxicol 29(3): 323-332. PubMed |
Showing studies 26-50 of 145